Abich Financial Wealth Management’s AstraZeneca AZN Stock Holding History

Abich Financial Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.61K	Buy	+11	New	+$1.67K	﹤0.01%	589

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Abich Financial Wealth Management's AZN Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in AstraZeneca (AZN) in Q3 2025: 11 shares worth $1.61K. The stake represents ﹤0.01% of the portfolio and ranks #589 among its holdings.

1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Abich Financial Wealth Management held 11 shares of AstraZeneca worth $1.61K as of Q3 2025.
AstraZeneca was a new Abich Financial Wealth Management position in Q3 2025.
AstraZeneca made up ﹤0.01% of Abich Financial Wealth Management's portfolio in Q3 2025, its #589 holding.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.